Ketamine infusions show promise for severe BPD in early trial
NCT ID NCT07099534
First seen May 12, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This pilot study tests whether two low-dose ketamine infusions, given 24 hours apart, can quickly reduce severe borderline personality disorder (BPD) symptoms. 38 adults with severe BPD will receive the infusions alongside their usual care and be followed for 3 months. The main goal is to see if symptoms improve 9 days after the first infusion.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER (BPD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Toulouse Purpan University Hospital, Head of Psychiatry Clinic in the UF3 department
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.